Search research articles
Contact Us
Filters
Showing results (31-40 of 115) with videos related to
Page
of 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2012
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
A A Argyriou, R Velasco, C Briani, et al.
European Journal of Neurology
|
December 21, 2012
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study
A A Argyriou, C Briani, G Cavaletti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2019
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials
S Cascinu, D Poli, A Zaniboni, et al.
British Journal of Cancer
|
March 14, 2007
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
E Franceschi, G Cavallo, S Lonardi, et al.
ESMO Open
|
August 13, 2025
Differentiating low tumor burden from oligometastatic disease in colorectal cancer: a call for individualized therapeutic approaches
M C de Grandis, I Baraibar, O Prior, et al.
British Journal of Cancer
|
January 17, 2013
Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
R Bertorelle, M Briarava, E Rampazzo, et al.
British Journal of Cancer
|
June 4, 2014
Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab
E Zulato, F Bergamo, A De Paoli, et al.
ESMO Open
|
April 11, 2025
Claudin 18.2: a promising actionable target in biliary tract cancers
V Angerilli, D Sacchi, M Rizzato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2010
Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial
R Labianca, A Sobrero, L Isa, et al.
Neurology
|
December 14, 2011
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions
J S Tzartos, G Khan, A Vossenkamper, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 115) with videos related to
Sort By:
Page
of 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2012
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
A A Argyriou, R Velasco, C Briani, et al.
European Journal of Neurology
|
December 21, 2012
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study
A A Argyriou, C Briani, G Cavaletti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2019
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials
S Cascinu, D Poli, A Zaniboni, et al.
British Journal of Cancer
|
March 14, 2007
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
E Franceschi, G Cavallo, S Lonardi, et al.
ESMO Open
|
August 13, 2025
Differentiating low tumor burden from oligometastatic disease in colorectal cancer: a call for individualized therapeutic approaches
M C de Grandis, I Baraibar, O Prior, et al.
British Journal of Cancer
|
January 17, 2013
Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
R Bertorelle, M Briarava, E Rampazzo, et al.
British Journal of Cancer
|
June 4, 2014
Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab
E Zulato, F Bergamo, A De Paoli, et al.
ESMO Open
|
April 11, 2025
Claudin 18.2: a promising actionable target in biliary tract cancers
V Angerilli, D Sacchi, M Rizzato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2010
Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial
R Labianca, A Sobrero, L Isa, et al.
Neurology
|
December 14, 2011
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions
J S Tzartos, G Khan, A Vossenkamper, et al.
Page
of 12